<DOC>
	<DOCNO>NCT00844155</DOCNO>
	<brief_summary>This propose pharmacokinetic study test hypothesis critically ill patient respiratory failure require mechanical ventilation might anticipate needed treat patient severe influenza pneumonia , oseltamivir administer enterally via nasogastric tube , without concomitant food alimentation , similar oral bioavailability observe ambulatory adult ill influenza oseltamivir therapy 75 mg BID efficacious well tolerate . Additionally , experiment test hypothesis increase dose ( 150 mg ) , without concomitant enteral feeding , show proportionate increase bioavailability . Relative oral bioavailability assess plasma concentration vs. time 12 hr urinary recovery drug 0 48 hrs administration .</brief_summary>
	<brief_title>Study Relative Oral Bioavailability Antiflu Medicine Oseltamivir Intensive Care Unit</brief_title>
	<detailed_description>Not require</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>patient admit Intensive Care Unit require mechanical ventilation due respiratory failure must within age 1875 yr patient unable enteral feed intolerance oseltamivir pregnancy gastrointestinal malabsorptive disease intestinal bypass surgery diarrhea ( &gt; 2 loose bowel movement per day ) receipt prokinetic medication ( metoclopramide , domperidone , erythromycin ) severe liver disease ( hepatocellular enzyme &gt; 3 time upper limit normal ) renal failure ( CockroftGault Creatinine Clearance &lt; 30 ml/min , Dialysis dependant ) cystic fibrosis intoxication drug overdose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Prevention treatment influenza ventilate patient</keyword>
</DOC>